4.5 Review

Immunoregulatory molecules are master regulators of inflammation during the immune response

Journal

FEBS LETTERS
Volume 586, Issue 18, Pages 2897-2905

Publisher

WILEY
DOI: 10.1016/j.febslet.2012.07.032

Keywords

Immunoregulatory molecules; Tolerance; Treg; Inflammation; Autoimmune diseases

Funding

  1. Spanish Ministry of the Economy
  2. Pro-CNIC Foundation
  3. [SAF2011-25834]
  4. [ERC-2011-AdG294340-GENTRIS]

Ask authors/readers for more resources

The balance between pro- and anti-inflammatory signalling is critical to maintain the immune homeostasis under physiological conditions as well as for the control of inflammation in different pathological settings. Recent progress in the signalling pathways that control this balance has led to the development of novel therapeutic agents for diseases characterized by alterations in the activation/suppression of the immune response. Different molecules have a key role in the regulation of the immune system, including the receptors PD-1 (Programmed cell Death 1), CTLA-4 (Cytotoxic T-Lymphocyte Antigen 4) and galectins; or the intracellular enzyme IDO (indoleamine 2,3-dioxygenase). In addition, other molecules as CD69, AhR (Aryl hydrocarbon Receptor), and GADD45 (Growth Arrest and DNA Damage-inducible 45) family members, have emerged as potential targets for the regulation of the activation/suppression balance of immune cells. This review offers a perspective on well-characterized as well as emergent negative immune regulatory molecules in the context of autoimmune inflammatory diseases. (C) 2012 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Rationale and design of the BA-SCAD (Beta-blockers and Antiplatelet agents in patients with Spontaneous Coronary Artery Dissection) randomized clinical trial

Fernando Alfonso, Jose M. de la Torre Hernandez, Borja Ibanez, Manel Sabate, Manuel Pan, Rajiv Gulati, Jacqueline Saw, Dominick J. Angiolillo, David Adlam, Francisco Sanchez-Madrid

Summary: BA-SCAD is a clinical trial aimed at evaluating the efficacy of pharmacological therapy in patients with SCAD. Patients will be randomly assigned to different treatment methods, and the results will be evaluated based on primary efficacy and safety endpoints. In addition, a comprehensive set of additional substudies will be conducted to gain a holistic understanding of this unique disease.

REVISTA ESPANOLA DE CARDIOLOGIA (2022)

Article Immunology

Poly I:C and STING agonist-primed DC increase lymphoid tissue polyfunctional HIV-1-specific CD8+ T cells and limit CD4+ T-cell loss in BLT mice

Marta Calvet-Mirabent, Daniel T. Claiborne, Maud Deruaz, Serah Tanno, Carla Serra, Cristina Delgado-Arevalo, Ildefonso Sanchez-Cerrillo, Ignacio de Los Santos, Jesus Sanz, Lucio Garcia-Fraile, Francisco Sanchez-Madrid, Arantzazu Alfranca, Maria Angeles Munoz-Fernandez, Todd M. Allen, Maria J. Buzon, Alejandro Balazs, Vladimir Vrbanac, Enrique Martin-Gayo

Summary: The combination of 2‘3’-c ' diAM(PS)2 and Poly I:C as adjuvants can enhance DCs' ability to induce polyfunctional HIV-1 specific CD8(+) T-cell responses, reducing the severity of CD4(+) T-cell depletion following HIV-1 infection, and preserving the specific polyfunctional responses of CD8(+) T cells. The priming of DCs with PolyI:C and STING agonists may be useful for future HIV-1 vaccine studies.

EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

Article Immunology

CD4+T Cell Immune Specificity Changes After Vaccination in Healthy And COVID-19 Convalescent Subjects

Laura Esparcia-Pinedo, Pedro Martinez-Fleta, Noelia Ropero, Paula Vera-Tome, Hugh T. Reyburn, Jose M. Casasnovas, Jose M. Rodriguez Frade, Mar Vales-Gomez, Carlos Vilches, Enrique Martin-Gayo, Cecilia Munoz-Calleja, Francisco Sanchez-Madrid, Arantzazu Alfranca

Summary: The immune response to the SARS-CoV-2 vaccination is important for developing new vaccines and optimizing prevention strategies. Analysis of the adaptive immunity in healthy donors and convalescent individuals before and after vaccination revealed specific changes in CD4+ T cell reactivity and antibody levels.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

A Differential Signature of Circulating miRNAs and Cytokines Between COVID-19 and Community-Acquired Pneumonia Uncovers Novel Physiopathological Mechanisms of COVID-19

Pedro Martinez-Fleta, Paula Vera-Tome, Maria Jimenez-Fernandez, Silvia Requena, Emilia Roy-Vallejo, Ancor Sanz-Garcia, Marta Lozano-Prieto, Celia Lopez-Sanz, Alicia Vara, Angel Lancho-Sanchez, Enrique Martin-Gayo, Cecilia Munoz-Calleja, Arantzazu Alfranca, Isidoro Gonzalez-Alvaro, Jose Maria Galvan-Roman, Javier Aspa, Hortensia de la Fuente, Francisco Sanchez-Madrid

Summary: This study compared plasma miRNA and cytokine profiles between COVID-19 and other community-acquired pneumonias (CAP), revealing 15 dysregulated miRNAs and differential cytokine signatures. These findings provide new insights into the etiopathological mechanisms of COVID-19.

FRONTIERS IN IMMUNOLOGY (2022)

Article Cell Biology

Cross-reactive cellular, but not humoral, immunity is detected between OC43 and SARS-CoV-2 NPs in people not infected with SARS-CoV-2: Possible role of cTFH cells

Alvaro Fernando Garcia-Jimenez, Yaiza Caceres-Martell, Daniel Fernandez-Soto, Pedro Martinez Fleta, Jose M. Casasnovas, Francisco Sanchez-Madrid, Jose Miguel Rodriguez Frade, Mar Vales-Gomez, Hugh T. Reyburn

Summary: Several unanswered questions remain about humoral and cellular immunity to SARS-CoV-2, including whether preexisting memory T or B cells in unexposed individuals can recognize and suppress COVID-19. Research has shown that while some unexposed individuals have cross-reactive T cell responses, these responses are weak in aspects like T-FH expansion, which may impact the generation of effective antibodies against SARS-CoV-2. Understanding these differences in cellular responses is crucial for advancing our knowledge of immunity to SARS-CoV-2.

JOURNAL OF LEUKOCYTE BIOLOGY (2022)

Article Multidisciplinary Sciences

Altered CXCR4 dynamics at the cell membrane impairs directed cell migration in WHIM syndrome patients

Eva M. Garcia-Cuesta, Jose Miguel Rodriguez-Frade, Sofia R. Gardeta, Gianluca D'Agostino, Pablo Martinez, Blanca Soler Palacios, Graciela Cascio, Tobias Wolf, Nicolas Mateos, Rosa Ayala-Bueno, Cesar A. Santiago, Pilar Lucas, Lucia Llorente, Luis M. Allende, Luis Ignacio Gonzalez-Granado, Noa Martin-Cofreces, Pedro Roda-Navarro, Federica Sallusto, Francisco Sanchez-Madrid, Maria F. Garcia-Parajo, Laura Martinez-Munoz, Mario Mellado

Summary: This study reveals that the truncated mutant chemokine receptor CXCR4(R334X) associated with WHIM syndrome fails to nanoclusterize after CXCL12 stimulation, affecting cell spatial organization and mobility, and causing multiple phalloidin-positive protrusions in cells. The inappropriate activation of beta-arrestin1 by CXCR4(R334X) leads to inadequate actin cytoskeleton remodeling, disrupting the balance between activated and deactivated cofilin.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Immunology

Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination

Laura Esparcia-Pinedo, Ayla Yarci-Carrion, Gloria Mateo-Jimenez, Noelia Ropero, Laura Gomez-Cabanas, Angel Lancho-Sanchez, Patricia Almendro-Vazquez, Enrique Martin-Gayo, Estela Paz-Artal, Francisco Sanchez-Madrid, Fernando Moldenhauer, Ainhoa Gutierrez-Cobos, Diego Real de Asua, Arantzazu Alfranca

Summary: This study found that individuals with Down syndrome (DS) develop an effective immune response to SARS-CoV-2 vaccination. The cellular and humoral responses to the vaccine were observed in DS individuals after 1 to 3 months and 6 months, with an effective immune response observed in 98% of DS individuals after 6 months.

CLINICAL INFECTIOUS DISEASES (2023)

Article Biology

Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses

Sara G. Dosil, Sheila Lopez-Cobo, Ana Rodriguez-Galan, Irene Fernandez-Delgado, Marta Ramirez-Huesca, Paula Milan-Rois, Milagros Castellanos, Alvaro Somoza, Manuel Jose Gomez, Hugh T. Reyburn, Mar Vales-Gomez, Francisco Sanchez Madrid, Lola Fernandez-Messina

Summary: NK cells and their secreted EVs have immunomodulatory roles, promoting Th1 responses and activating monocytes and moDCs. MicroRNAs of NK-EVs target molecules involved in Th1 responses and partially recapitulate their effects in mice.

ELIFE (2022)

Article Medicine, General & Internal

Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in with HIV

Marta Calvet-Mirabent, Ildefonso Sanchez Cerillo, Noa Martin-Corfrees, Pedro Martinez-Fleta, Hortensia de la Fuente, Ilya Tsukalov, Cristina Delgado-Arevelo, Maria Jose Calzo, Ignaciode de los Santos, Jesus Sanz, Lucio Garcia-Fraile, Francisco Sanchez Madid, Arantzazu Alfranca, Maria Angles Munoz-Ferandez, Maria J. Buzon, Enrique Martin-Gayo

Summary: This study identifies specific immunometabolic parameters associated with functional restoration of CD8+ T cells in people living with HIV-1 on long-term ART. The findings suggest that CD8+ T cells from these patients show improved polyfunctionality and capacity to eliminate infected CD4+ T cells after treatment with Gag-adjuvant-primed DC. However, CD8+ T cells from patients on short-term ART show limited functional improvement after DC treatment, which is associated with altered memory cell subsets, increased expression of PD1 and TIGIT, and reduced metabolic activity upon TCR activation. Restoring the function of CD8+ T cells from these patients can be achieved through combined treatment with anti-PD1 and anti-TIGIT antibodies and a glycolysis promoting drug.

EBIOMEDICINE (2022)

Article Chemistry, Multidisciplinary

Alarming and Calming: Opposing Roles of S100A8/S100A9 Dimers and Tetramers on Monocytes

Antonella Russo, Hendrik Schuermann, Matthias Brandt, Katja Scholz, Anna Livia L. Matos, David Grill, Julian Revenstorff, Max Rembrink, Meike von Wulffen, Lena Fischer-Riepe, Peter J. Hanley, Hans Haecker, Monika Pruenster, Francisco Sanchez-Madrid, Sven Hermann, Luisa Klotz, Volker Gerke, Timo Betz, Thomas Vogl, Johannes Roth

Summary: It has been demonstrated that S100A8/S100A9 tetramers can weaken the inflammatory response of leukocytes in vitro and in vivo, and this is mediated by the interaction between S100A8/S100A9 tetramers and CD69, rather than the binding of S100A8/S100A9 dimers to TLR4. These findings reveal the important role of the quaternary structure of S100 proteins in regulating leukocyte inflammatory responses.

ADVANCED SCIENCE (2022)

Article Immunology

Extracellular vesicles from Listeria monocytogenes-infected dendritic cells alert the innate immune response

Raul Izquierdo-Serrano, Irene Fernandez-Delgado, Olga Moreno-Gonzalo, Enrique Martin-Gayo, Diego Calzada-Fraile, Marta Ramirez-Huesca, Inmaculada Jorge, Emilio Camafeita, Joaquin Abian, Miguel Vicente-Manzanares, Esteban Veiga, Jesus Vazquez, Francisco Sanchez-Madrid

Summary: Communication through cell-cell contacts and extracellular vesicles allows immune cells to coordinate their responses against pathogens. The proteins and nucleic acids loaded into extracellular vesicles play a crucial role in this process. Acetylation, controlled by HDAC6, is a mechanism of cellular retention during protein sorting to exosomes. During infection, protein content of dendritic cells and their secreted extracellular vesicles change and become enriched in antiviral proteins. These extracellular vesicles can induce anti-pathogenic gene expression in recipient cells, leading to protection against subsequent viral infection.

FRONTIERS IN IMMUNOLOGY (2022)

Article Medicine, Research & Experimental

NLRC4-mediated activation of CD1c+DC contributes to perpetuation of synovitis in rheumatoid arthritis

Cristina Delgado-Arevalo, Marta Calvet-Mirabent, Ana Triguero-Martinez, Enrique Vazquez de Luis, Alberto Benguria-Filippini, Raquel Largo, Diego Calzada-Fraile, Olga Popova, Ildefonso Sanchez-Cerrillo, Ilya Tsukalov, Roberto Moreno-Vellisca, Hortensia de la Fuente, Gabriel Herrero-Beaumont, Almudena Ramiro, Francisco Sanchez-Madrid, Santos Castaneda, Ana Dopazo, Isidoro Gonzalez alvaro, Enrique Martin-Gayo

Summary: This study assessed the characteristics of CD1c+ and CD141+ cDC and monocytes in patients with RA, revealing the association between the presence of CD1c+ cDC in the synovial membrane and the higher expression of CCR2 and CD64. Additionally, synovial CD1c+ cDC exhibited increased proinflammatory cytokine expression and the ability to induce pathogenic T cells. The crosstalk between Fcγ receptors and NLRC4 was identified as a potential mechanism mediating the pathogenic activation, CD64 upregulation, and functional specialization of CD1c+ cDC in response to dsDNA-IgG in patients with RA.

JCI INSIGHT (2022)

Article Multidisciplinary Sciences

Erythroid SLC7A5/SLC3A2 amino acid carrier controls red blood cell size and maturation

Antonio Bouthelier, Lucia Fernandez-Arroyo, Claudia Mesa-Ciller, Danay Cibrian, Noa Beatriz Martin-Cofreces, Raquel Castillo-Gonzalez, Macarena Calero, Diego Herraez-Aguilar, Andrea Guajardo-Grence, Ana Maria Pacheco, Ana Marcos-Jimenez, Borja Quiroga, Marta Morado, Francisco Monroy, Cecilia Munoz-Calleja, Francisco Sanchez-Madrid, Andres A. Urrutia, Julian Aragones

Summary: Inhibition of the amino acid carrier SLC7A5/SLC3A2 has been extensively studied in tumor biology, but its role in physiological conditions is not well understood. This study demonstrates that the SLC7A5/SLC3A2 heterodimer is present during erythroid differentiation but absent in mature red blood cells. Erythropoietin induces expression of SLC7A5/SLC3A2 in reticulocytes, and its deficiency leads to reduced size and hemoglobin content in circulating red blood cells. These findings highlight the importance of SLC7A5/SLC3A2 in reticulocyte maturation and maintaining proper characteristics of red blood cells.

ISCIENCE (2023)

Article Medicine, Research & Experimental

CD69 expression on regulatory T cells protects from immune damage after myocardial infarction

Rafael Blanco-Dominguez, Hortensia de la Fuente, Cristina Rodriguez, Laura Martin-Aguado, Raquel Sanchez-Diaz, Rosa Jimenez-Alejandre, Iker Rodriguez-Arabaolaza, Andrea Curtabbi, Marcos M. Garcia-Guimaraes, Alberto Vera, Fernando Rivero, Javier Cuesta, Luis J. Jimenez-Borreguero, Alberto Cecconi, Albert Duran-Cambra, Manel Tauron, Judith Alonso, Hector Bueno, Maria Villalba-Orero, Jose Antonio Enriquez, Simon C. Robson, Fernando Alfonso, Francisco Sanchez-Madrid, Jose Martinez-Gonzalez, Pilar Martin

Summary: Increasing CD69 expression on T cells after myocardial infarction may play an important role in controlling immune response and improving cardiac function. Clinical data suggests that increased CD69 expression is associated with a lower risk of heart failure.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Medicine, General & Internal

SARS-CoV-2 Viremia Precedes an IL6 Response in Severe COVID-19 Patients: Results of a Longitudinal Prospective Cohort

Emilia Roy-Vallejo, Laura Cardenoso, Ana Triguero-Martinez, Marta Chicot Llano, Nelly Zurita, Elena Avalos, Ana Barrios, Julia Hernando, Javier Ortiz, Sebastian C. Rodriguez-Garcia, Marianela Ciudad Sanudo, Celeste Marcos, Elena Garcia Castillo, Leticia Fontan Garcia-Rodrigo, Begona Gonzalez, Rosa Mendez, Isabel Iturrate, Ancor Sanz-Garcia, Almudena Villa, Ana Sanchez-Azofra, Begona Quicios, David Arribas, Jesus Alvarez Rodriguez, Pablo Patino, Marina Trigueros, Miren Uriarte, Alexandra Martin-Ramirez, Cristina Arevalo Roman, Jose Maria Galvan-Roman, Rosario Garcia-Vicuna, Julio Ancochea, Cecilia Munoz-Calleja, Elena Fernandez-Ruiz, Rafael de la Camara, Carmen Suarez Fernandez, Isidoro Gonzalez-Alvaro, Diego A. Rodriguez-Serrano, PREDINMUN COVID Grp

Summary: This study aimed to evaluate the relationship between SARS-CoV-2 viral load and IL6 levels in COVID-19 patients. The results showed that in patients with worse outcomes, there was an early peak of SARS-CoV-2 viral load followed by an increase in IL6 levels. Monitoring viral load during the first week after symptom onset may help predict disease severity in COVID-19 patients.

FRONTIERS IN MEDICINE (2022)

No Data Available